Low-Cost Pot Stocks To Consider, According To SOMAÍ Pharmaceuticals CEO Mike Sassano
SOMAÍ Pharmaceuticals Ltd. co-founder and CEO Michael Sassano recently spoke to Benzinga about a particular value buy that's piqued his interest.
He also touched on recent market fluctuations, the global marketplace's development and what it means to investors.
